Tessa Therapeutics to build commercial-scale facility for VST therapies

Tessa Therapeutics to build commercial-scale facility for VST therapies

Source: 
Fierce Pharma
snippet: 

A Singapore biotech that has been manufacturing virus-specific T cells for its clinical studies is ready to scale up. Tessa Therapeutics will build a 90,000 square foot global cell therapy manufacturing facility in Singapore.